Search
Sign In
Sign In
Sources
11 Total Sources
FDA Approves Mounjaro to Cut 8% Cardiovascular Risk in Type 2 Diabetes
Left
17%
Center
50%
Right
33%
All
11
Left
1
Center
3
Right
2
Others
5
USA TODAY
21h ago
FDA Approves Eli Lilly's Mounjaro for Cardiovascular Risk Reduction in Type 2 Diabetes
Yahoo! Voices
3h ago
Lilly's Mounjaro wins US label expansion for cardiovascular risk reduction
BioPharm International
21h ago
FDA Approves Mounjaro to Lower Cardiovascular Risk in Type 2 Diabetes Based on SURPASS-CVOT | BioPharm International
Geo News
43m ago
FDA approves Lilly's Mounjaro to reduce cardiovascular risk in type 2 diabetes patients
baha news
21h ago
Eli Lilly's Mounjaro gets FDA approval for heart disease - Breaking The News
investorshangout.com
13h ago
FDA Approval of Mounjaro: Big Wins in Diabetes Care - Investors Hangout
Reuters
21h ago
US FDA approves Lilly's Mounjaro to reduce cardiovascular risk | Reuters
The Wall Street Journal
21h ago
FDA Approves Eli Lilly's Mounjaro for Weight Loss in the U.S. Under the Name Zepbound - WSJ
Indianapolis Business Journal
5h ago
FDA approves Lilly's Mounjaro to reduce cardiovascular risk – Indianapolis Business Journal
StockTitan
21h ago
Eli Lilly Mounjaro Approved to Reduce Heart Risk | LLY Stock News
BioSpace
21h ago
Lilly joins Novo in cardiovascular space after FDA nod for GLP-1/GIP agonist Mounjaro - BioSpace